BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2539980)

  • 1. Cellular tolerance to adenosine receptor-mediated inhibition of lipolysis: altered adenosine 3',5'-monophosphate metabolism and protein kinase activation.
    Hoffman BB; Prokocimer P; Thomas JM; Vagelos R; Chang H; Reaven GM
    Endocrinology; 1989 May; 124(5):2434-42. PubMed ID: 2539980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes.
    Hoffman BB; Chang H; Dall'Aglio E; Reaven GM
    J Clin Invest; 1986 Jul; 78(1):185-90. PubMed ID: 3013937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes.
    Elks ML; Jackson M; Manganiello VC; Vaughan M
    Am J Physiol; 1987 Mar; 252(3 Pt 1):C342-8. PubMed ID: 3030132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats.
    Vannucci SJ; Klim CM; Martin LF; LaNoue KF
    Am J Physiol; 1989 Dec; 257(6 Pt 1):E871-8. PubMed ID: 2558574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gi down-regulation as a mechanism for heterologous desensitization in adipocytes.
    Green A; Milligan G; Dobias SB
    J Biol Chem; 1992 Feb; 267(5):3223-9. PubMed ID: 1737778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thyroid hormone on regulation of lipolysis and adenosine 3',5'-monophosphate metabolism in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1985 Sep; 117(3):947-53. PubMed ID: 2410243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism for desensitization of beta-adrenergic receptor-stimulated lipolysis in adipocytes from rats harboring pheochromocytoma.
    Prokocimer PG; Maze M; Vickery RG; Hoffman BB
    Endocrinology; 1988 Jul; 123(1):528-33. PubMed ID: 2838264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation and inhibition of lipolysis in isolated rat adipocytes: evidence for age-related changes in responses to forskolin and PGE1.
    Hoffman BB; Chang H; Reaven GM
    Horm Metab Res; 1987 Aug; 19(8):358-60. PubMed ID: 2822560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for impaired coupling of receptors to Gi protein in adipocytes from streptozocin-induced diabetic rats.
    Green A; Johnson JL
    Diabetes; 1991 Jan; 40(1):88-94. PubMed ID: 1849851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents.
    Kuroda M; Honnor RC; Cushman SW; Londos C; Simpson IA
    J Biol Chem; 1987 Jan; 262(1):245-53. PubMed ID: 3025204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Winner of the 1988 NAASO Young Investigator Award. Regulation of fat cell adenylate cyclase in young Zucker (fa/fa) rats: alterations in GTP sensitivity of adenosine A1 mediated inhibition.
    Vannucci SJ; Klim CM; LaNoue KF; Martin LF
    Int J Obes; 1990; 14 Suppl 3():125-34. PubMed ID: 1964933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine analogues on basal, prostaglandin E1- and forskolin-stimulated cyclic AMP formation in intact neuroblastoma cells.
    Murphy MG; Byczko Z
    Biochem Pharmacol; 1989 Oct; 38(19):3289-95. PubMed ID: 2554919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent changes in beta-adrenergic receptor subtypes and adenylyl cyclase activation in adipocytes from Fischer 344 rats.
    Gettys TW; Rohlfs EM; Prpic V; Daniel KW; Taylor IL; Collins S
    Endocrinology; 1995 May; 136(5):2022-32. PubMed ID: 7720650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine receptor-mediated effects by nonmetabolizable adenosine analogs in preovulatory rat granulosa cells: a putative local regulatory role of adenosine in the ovary.
    Billig H; Thelander H; Rosberg S
    Endocrinology; 1988 Jan; 122(1):52-61. PubMed ID: 2826114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
    Smith CJ; Manganiello VC
    Mol Pharmacol; 1989 Mar; 35(3):381-6. PubMed ID: 2538713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative differences in the cyclic AMP-lipolysis relationships for isoproterenol and forskolin.
    Allen DO; Quesenberry JT
    J Pharmacol Exp Ther; 1988 Mar; 244(3):852-8. PubMed ID: 2855246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
    Elks ML; Manganiello VC
    Endocrinology; 1985 May; 116(5):2119-21. PubMed ID: 2985373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.